Drugs / Cu[64]-25%CANF-Comb
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02498379 | Oct 2014 → Apr 2015 | atherosclerosis | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cu[64]-25%CANF-Comb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02498379 ↗ |
| Modality | Diagnostic / imaging agent | “novel atherosclerotic imaging PET radiotracer” NCT02498379 ↗ |
| Route | Intravenous | “Intravenous injection of 4-8 mCi of Cu\[64\]-25%CANF-Comb” NCT02498379 ↗ |